Literature DB >> 4365666

Neurotoxicity of commonly used antineoplastic agents (second of two parts).

H D Weiss, M D Walker, P H Wiernik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4365666     DOI: 10.1056/NEJM197407182910305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  33 in total

1.  Partially reversible nerve deafness due to vincristine.

Authors:  H Yousif; S G Richardson; W A Saunders
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  Vincristine exacerbates asymptomatic Charcot-Marie-tooth disease with a novel EGR2 mutation.

Authors:  Tomonori Nakamura; Akihiro Hashiguchi; Shinsuke Suzuki; Kimiharu Uozumi; Shoko Tokunaga; Hiroshi Takashima
Journal:  Neurogenetics       Date:  2012-01-25       Impact factor: 2.660

3.  Current status of psychological research in organ transplantation.

Authors:  J R Rodrigue; A F Greene; S R Boggs
Journal:  J Clin Psychol Med Settings       Date:  1994-03

Review 4.  Clinical features, pathogenesis and management of drug-induced seizures.

Authors:  G Zaccara; G C Muscas; A Messori
Journal:  Drug Saf       Date:  1990 Mar-Apr       Impact factor: 5.606

Review 5.  Antineoplastic drugs in 1990. A review (Part II).

Authors:  D J Black; R B Livingston
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

6.  Drug-induced peripheral neuropathies.

Authors:  Z Argov; F L Mastaglia
Journal:  Br Med J       Date:  1979-03-10

7.  Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells.

Authors:  K L King; G B Boder
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Can severe vincristine neurotoxicity be prevented?

Authors:  Z R Desai; H W Van den Berg; J M Bridges; R G Shanks
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report.

Authors:  W Scheithauer; H Ludwig; E Maida
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

10.  Measles inclusion-body encephalitis in a child with treated acute lymphoblastic leukaemia.

Authors:  H C Drysdale; L F Jones; D R Oppenheimer; A H Tomlinson
Journal:  J Clin Pathol       Date:  1976-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.